{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:10:14Z","timestamp":1790651414240,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.neuropharm.2013.11.003","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T06:55:28Z","timestamp":1385016928000},"page":"112-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Bladder pain relief by HMGB1 neutralization and soluble thrombomodulin in mice with cyclophosphamide-induced cystitis"],"prefix":"10.1016","volume":"79","author":[{"given":"Junichi","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Ishikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Tsubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Tsujiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsufumi","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.11.003_bib1","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1128\/iai.58.9.2862-2868.1990","article-title":"Inactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides","volume":"58","author":"Baker","year":"1990","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0304-3959(01)00354-2","article-title":"A\u00a0new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats","volume":"94","author":"Chacur","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2013.11.003_bib3","doi-asserted-by":"crossref","first-page":"39888","DOI":"10.1074\/jbc.M110.128348","article-title":"High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity","volume":"285","author":"Evankovich","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1742-2094-9-180","article-title":"The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain","volume":"9","author":"Feldman","year":"2012","journal-title":"J.\u00a0Neuroinflamm."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cyto.2010.02.021","article-title":"HMGB1, a potent proinflammatory cytokine in sepsis","volume":"51","author":"Huang","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.neuropharm.2013.11.003_bib6","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/ATVBAHA.107.150631","article-title":"Proteolytic cleavage of high mobility group box 1 protein by thrombin\u2013thrombomodulin complexes","volume":"28","author":"Ito","year":"2008","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2013.11.003_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1538-7836.2011.04319.x","article-title":"Thrombomodulin: protectorate god of the vasculature in thrombosis and inflammation","volume":"9","author":"Ito","year":"2011","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib8","doi-asserted-by":"crossref","first-page":"8352","DOI":"10.1523\/JNEUROSCI.22-19-08352.2002","article-title":"Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS\/PN3)-null mice","volume":"22","author":"Laird","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1423-0127-19-34","article-title":"The role of thrombomodulin lectin-like domain in inflammation","volume":"19","author":"Li","year":"2012","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib10","first-page":"203","article-title":"Establishment of in\u00a0vitro binding assay of high mobility group box-1 and S100A12 to receptor for advanced glycation endproducts: heparin's effect on binding","volume":"63","author":"Liu","year":"2009","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/j.neuropharm.2013.11.003_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12264-012-1219-5","article-title":"Emerging role of toll-like receptors in the control of pain and itch","volume":"28","author":"Liu","year":"2012","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1433.059","article-title":"The RAGE pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy","volume":"1126","author":"Lukic","year":"2008","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.tibs.2012.09.003","article-title":"The high mobility group box: the ultimate utility player of a cell","volume":"37","author":"Malarkey","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1476-5381.2012.02060.x","article-title":"Involvement of the endogenous hydrogen sulfide\/Cav 3.2 T-type Ca2+ channel pathway in cystitis-related bladder pain in mice","volume":"167","author":"Matsunami","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib15","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.pain.2011.02.019","article-title":"ONO-8130, a selective prostanoid EP1 receptor antagonist, relieves bladder pain in mice with cyclophosphamide-induced cystitis","volume":"152","author":"Miki","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2013.11.003_bib16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00001721-199707000-00003","article-title":"The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis)","volume":"8","author":"Mohri","year":"1997","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.neuropharm.2013.11.003_bib17","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.2337\/db06-0221","article-title":"RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin","volume":"55","author":"Myint","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2013.11.003_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/eujp.1998.0105","article-title":"Cyclophosphamide cystitis in mice: behavioural characterisation and correlation with bladder inflammation","volume":"3","author":"Olivar","year":"1999","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2013.11.003_bib19","doi-asserted-by":"crossref","first-page":"E692","DOI":"10.1097\/BRS.0b013e3181ecd675","article-title":"Anti-HMGB1 neutralization antibody improves pain-related behavior induced by application of autologous nucleus pulposus onto nerve roots in rats","volume":"36","author":"Otoshi","year":"2011","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.neuropharm.2013.11.003_bib20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.brainresbull.2012.03.002","article-title":"High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes","volume":"88","author":"Ren","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.pain.2010.03.023","article-title":"Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury","volume":"149","author":"Shibasaki","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2013.11.003_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in inflammation and cancer","volume":"28","author":"Sims","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib23","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/cas.12133","article-title":"Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells","volume":"104","author":"Takeuchi","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib24","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.bbrc.2010.04.086","article-title":"Spinal high-mobility group box 1 contributes to mechanical allodynia in a rat model of bone cancer pain","volume":"395","author":"Tong","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice","volume":"285","author":"Wang","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2013.11.003_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neulet.2007.05.043","article-title":"Pharmacological validation of a model of cystitis pain in the mouse","volume":"421","author":"Wantuch","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tips.2009.08.002","article-title":"The \u201ctoll\u201d of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia","volume":"30","author":"Watkins","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2013.11.003_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.it.2012.10.005","article-title":"High-mobility group box family of proteins: ligand and sensor for innate immunity","volume":"33","author":"Yanai","year":"2012","journal-title":"Trends Immunol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813005273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813005273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T11:14:15Z","timestamp":1656069255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813005273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":28,"alternative-id":["S0028390813005273"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.11.003","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bladder pain relief by HMGB1 neutralization and soluble thrombomodulin in mice with cyclophosphamide-induced cystitis","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}